Current pharmacological treatment for fibrous dysplasia and perspectives for the future

Joint Bone Spine

Volumn 72, Issue 3, 2005, Pages 196-198

  Chapurlat, Roland ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Bisphosphonates; Fibrous dysplasia of bone; McCune Albright syndrome; Renal phosphate wasting; Risedronate

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PAMIDRONIC ACID; PHOSPHATE; PLACEBO; RISEDRONIC ACID; VITAMIN D;

ALBRIGHT SYNDROME; ANALGESIA; ANALGESIC ACTIVITY; BONE ATROPHY; BONE DENSITY; BONE PAIN; BONE SCINTISCANNING; BONE TURNOVER; CLINICAL TRIAL; DRUG EFFICACY; DRUG FEVER; EDITORIAL; FIBROUS DYSPLASIA; HUMAN; HYPOPHOSPHATEMIA; MOSAICISM; OSTEOMALACIA; PAGET BONE DISEASE; QUALITY OF LIFE; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 17844392356     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.08.001     Document Type: Editorial

References (17)

1. L.S. Weinstein, A. Shenker, P.V. Gejman, M.J. Merino, E. Friedman, and A.M. Spiegel Activating mutations of the stimulatory G protein in the McCune-Albright syndrome N. Engl. J. Med. 325 1991 1688 1695
2. G.A. Candeliere, F. Glorieux, J. Prud'homme, and R. St Arnaud Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia N. Engl. J. Med. 332 1995 1546 1551
3. T. Yamamoto, K. Ozono, S. Kasayama, K. Yoh, K. Hiroshima, and M. Takagi Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome J. Clin. Invest. 98 1996 30 35
4. A. Corsi, M.T. Collins, M. Riminucci, P.G.T. Howell, A. Boyde, and P. Gehron Robey Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations J. Bone Miner. Res. 18 2003 1235 1246
5. D. Liens, P.D. Delmas, and P.J. Meunier Long-term effects of intravenous pamidronate in fibrous dysplasia of bone Lancet 343 1994 953 954
6. R.D. Chapurlat, P.D. Delmas, D. Liens, and P.J. Meunier Long-term effects of intravenous pamidronate in fibrous dysplasia of bone J. Bone Miner. Res. 12 1997 1746 1752
7. R.D. Chapurlat, P. Hugueny, P.D. Delmas, and P.J. Meunier Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment Bone 35 2004 235 242
8. R.S. Weinstein Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density J. Bone Miner. Res. 12 1997 1314 1315
9. J.M. Lane, S.F. Khan, W.J. O'Connor, M. Nydick, J.P. Hommen, and R. Schneider Bisphosphonate therapy in fibrous dysplasia Clin. Orthop. 382 2001 6 12
10. R. Lala, P. Matarazzo, S. Bertelloni, F. Buzi, F. Rigon, and C. de:Sanctis Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome Acta Paediatr. 89 2000 188 193
11. G.C. Isaia, R. Lala, C. Defilippi, P. Matarazzo, M. Andreo, and C. Roggia Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia Calcif. Tissue Int. 71 2002 121 128
12. M.S. Parisi, B. Oliveri, and C.A. Mautalen Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia Bone 33 2003 582 588
13. H. Plotkin, F. Rauch, L. Zeitlin, C. Munns, R. Travers, and F.H. Glorieux Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone J. Clin. Endocrinol. Metab. 88 2003 4569 4575
14. M.T. Collins, C. Chebli, J. Jones, H. Kushner, M. Consugar, and P. Rinaldo Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia J. Bone Miner Res. 16 2001 806 813
15. M. Riminucci, M.T. Collins, N.S. Fedarko, N. Cherman, A. Corsi, and K.E. White FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting J. Clin. Invest. 112 2003 683 692
16. A.I. Leet, C. Chebli, H. Kushner, C.C. Chen, M.H. Kelly, and B.A. Brillante Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome J. Bone Miner Res. 19 2004 571 577
17. F.H. Glorieux, C.R. Scriver, T.M. Reade, H. Goldman, and A. Roseborough Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia N. Engl. J. Med. 287 1972 481 487